Cargando…
COVID-19: Therapeutics and Their Toxicities
SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is causing the COVID-19 pandemic. There is no current standard of care. Clinicians need to be mindful of the toxicity of a wide variety of possibly unfamiliar substances being tested or repurposed to treat COVID-19. The United States Food an...
Autores principales: | Chary, Michael A., Barbuto, Alexander F., Izadmehr, Sudeh, Hayes, Bryan D., Burns, Michele M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192319/ https://www.ncbi.nlm.nih.gov/pubmed/32356252 http://dx.doi.org/10.1007/s13181-020-00777-5 |
Ejemplares similares
-
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics)
por: Chary, Michael A., et al.
Publicado: (2022) -
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
por: Chary, Michael, et al.
Publicado: (2023) -
SUN-143 Prostatic Acid Phosphatase Is Not Regulated by Androgens During Prostate Development and Tumorigenesis
por: Izadmehr, Sudeh, et al.
Publicado: (2020) -
Prostatic Acid Phosphatase Is a Progenitor Cell Marker That Persists After Androgen Ablation
por: Izadmehr, Sudeh, et al.
Publicado: (2021) -
Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase
por: Quiroz-Munoz, Mariana, et al.
Publicado: (2019)